A citation-based method for searching scientific literature


List of co-cited articles
715 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
J Boyd, Y Sonoda, M G Federici, F Bogomolniy, E Rhei, D L Maresco, P E Saigo, L A Almadrones, R R Barakat, C L Brown,[...]. JAMA 2000
379
61

Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1.
S C Rubin, I Benjamin, K Behbakht, H Takahashi, M A Morgan, V A LiVolsi, A Berchuck, M G Muto, J E Garber, B L Weber,[...]. N Engl J Med 1996
343
51


Improved survival in women with BRCA-associated ovarian carcinoma.
Ilana Cass, Rae Lynn Baldwin, Taz Varkey, Roxana Moslehi, Steven A Narod, Beth Y Karlan. Cancer 2003
340
48

Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1.
H Aida, K Takakuwa, H Nagata, I Tsuneki, M Takano, S Tsuji, T Takahashi, T Sonoda, M Hatae, K Takahashi,[...]. Clin Cancer Res 1998
79
39

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
H A Risch, J R McLaughlin, D E Cole, B Rosen, L Bradley, E Kwan, E Jack, D J Vesprini, G Kuperstein, J L Abrahamson,[...]. Am J Hum Genet 2001
715
31

Effect of BRCA mutations on the length of survival in epithelial ovarian tumors.
Y Ben David, A Chetrit, G Hirsh-Yechezkel, E Friedman, B D Beck, U Beller, G Ben-Baruch, A Fishman, H Levavi, F Lubin,[...]. J Clin Oncol 2002
149
31

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.
Angela Chetrit, Galit Hirsh-Yechezkel, Yehuda Ben-David, Flora Lubin, Eitan Friedman, Siegal Sadetzki. J Clin Oncol 2008
224
30

"BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations.
David S P Tan, Christian Rothermundt, Karen Thomas, Elizabeth Bancroft, Rosalind Eeles, Susan Shanley, Audrey Ardern-Jones, Andrew Norman, Stanley B Kaye, Martin E Gore. J Clin Oncol 2008
321
30

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
23

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
22

Ovarian cancer survival in Ashkenazi Jewish patients with BRCA1 and BRCA2 mutations.
S J Ramus, A Fishman, P D Pharoah, S Yarkoni, M Altaras, B A Ponder. Eur J Surg Oncol 2001
38
57


Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
21

Failure of BRCA1 dysfunction to alter ovarian cancer survival.
Richard E Buller, Mark S Shahin, John P Geisler, Melanie Zogg, Barry R De Young, Charles S Davis. Clin Cancer Res 2002
42
45

Improved survival in BRCA2 carriers with ovarian cancer.
Tuya Pal, Jenny Permuth-Wey, Rachna Kapoor, Alan Cantor, Rebecca Sutphen. Fam Cancer 2007
48
39

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
18

Pathology of ovarian cancers in BRCA1 and BRCA2 carriers.
Sunil R Lakhani, Sanjiv Manek, Frederique Penault-Llorca, Adrienne Flanagan, Laurent Arnout, Samantha Merrett, Lesley McGuffog, Dawn Steele, Peter Devilee, Jan G M Klijn,[...]. Clin Cancer Res 2004
181
18


Contribution of BRCA1 mutations to ovarian cancer.
J F Stratton, S A Gayther, P Russell, J Dearden, M Gore, P Blake, D Easton, B A Ponder. N Engl J Med 1997
197
17

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
366
17

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer.
R Moslehi, W Chu, B Karlan, D Fishman, H Risch, A Fields, D Smotkin, Y Ben-David, J Rosenblatt, D Russo,[...]. Am J Hum Genet 2000
225
16

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
498
16

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.
S A Gayther, P Russell, P Harrington, A C Antoniou, D F Easton, B A Ponder. Am J Hum Genet 1999
92
16

Frequency of germline and somatic BRCA1 mutations in ovarian cancer.
A Berchuck, K A Heron, M E Carney, J M Lancaster, E G Fraser, V L Vinson, A M Deffenbaugh, A Miron, J R Marks, P A Futreal,[...]. Clin Cancer Res 1998
144
14

Histopathologic features of genetically determined ovarian cancer.
P A Shaw, J R McLaughlin, R P Zweemer, S A Narod, H Risch, R H M Verheijen, A Ryan, F H Menko, P Kenemans, I J Jacobs. Int J Gynecol Pathol 2002
83
16

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.
Mary-Claire King, Joan H Marks, Jessica B Mandell. Science 2003
14

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
14

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
14

Hallmarks of 'BRCAness' in sporadic cancers.
Nicholas Turner, Andrew Tutt, Alan Ashworth. Nat Rev Cancer 2004
13

Prognostic impact of BRCA1 pathogenic and BRCA1/BRCA2 unclassified variant mutations in patients with ovarian carcinoma.
Ewa Joanna Majdak, Jaroslaw Debniak, Tomasz Milczek, Cees J Cornelisse, Peter Devilee, Janusz Emerich, Jacek Jassem, Geertruida Hendrika De Bock. Cancer 2005
48
27

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene.
S A Gayther, J Mangion, P Russell, S Seal, R Barfoot, B A Ponder, M R Stratton, D Easton. Nat Genet 1997
334
12


Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers.
Amir A Jazaeri, Cindy J Yee, Christos Sotiriou, Kelly R Brantley, Jeff Boyd, Edison T Liu. J Natl Cancer Inst 2002
193
12

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
John R McLaughlin, Barry Rosen, Joel Moody, Tuya Pal, Isabel Fan, Patricia A Shaw, Harvey A Risch, Thomas A Sellers, Ping Sun, Steven A Narod. J Natl Cancer Inst 2013
94
12

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation.
S A Gayther, W Warren, S Mazoyer, P A Russell, P A Harrington, M Chiano, S Seal, R Hamoudi, E J van Rensburg, A M Dunning,[...]. Nat Genet 1995
425
11

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
J P Struewing, P Hartge, S Wacholder, S M Baker, M Berlin, M McAdams, M M Timmerman, L C Brody, M A Tucker. N Engl J Med 1997
11

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.
S A Narod, H Risch, R Moslehi, A Dørum, S Neuhausen, H Olsson, D Provencher, P Radice, G Evans, S Bishop,[...]. N Engl J Med 1998
384
11


Histopathology, FIGO stage, and BRCA mutation status of ovarian cancers from the Gilda Radner Familial Ovarian Cancer Registry.
Bruce A Werness, Susan J Ramus, Richard A DiCioccio, Alice S Whittemore, Kim Garlinghouse-Jones, Ingrid Oakley-Girvan, Yoshiaki Tsukada, Patricia Harrington, Simon A Gayther, Bruce A J Ponder,[...]. Int J Gynecol Pathol 2004
55
20

Survival analysis in familial ovarian cancer, a case control study.
R P Zweemer, R H Verheijen, J W Coebergh, I J Jacobs, P J van Diest, J J Gille, S Skates, F H Menko, L P Ten Kate, P Kenemans. Eur J Obstet Gynecol Reprod Biol 2001
20
55

BRCA1 mRNA expression levels predict for overall survival in ovarian cancer after chemotherapy.
Jennifer E Quinn, Colin R James, Gail E Stewart, Jude M Mulligan, Patricia White, Gary K F Chang, Paul B Mullan, Patrick G Johnston, Richard H Wilson, D Paul Harkin. Clin Cancer Res 2007
169
11

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
941
11

Chemosensitivity and outcome of BRCA1- and BRCA2-associated ovarian cancer patients after first-line chemotherapy compared with sporadic ovarian cancer patients.
P M L H Vencken, M Kriege, D Hoogwerf, S Beugelink, M E L van der Burg, M J Hooning, E M Berns, A Jager, M Collée, C W Burger,[...]. Ann Oncol 2011
125
11




Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
628
10

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
865
10

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Kathryn Alsop, Sian Fereday, Cliff Meldrum, Anna deFazio, Catherine Emmanuel, Joshy George, Alexander Dobrovic, Michael J Birrer, Penelope M Webb, Colin Stewart,[...]. J Clin Oncol 2012
680
10


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.